Order a test

Onconomics Plus RGCC

Onconomics Plus RGCC provides information about the effect of specific anti-cancer drugs, targeted therapies and natural treatments on the cancer cells in an individual patient.

During the test, a sample of blood or tissue is analysed to test how effective specific therapies and treatments are at suppressing cancer.

Together, the results of the extensive tests provide scientists and clinicians with a comprehensive breakdown of the most suitable and successful treatments for cancer. The results can be used by clinicians to design personalised and targeted cancer therapies with the highest chances of success.

Sample of the reportOrder a test

Test Details

Sample Type

Blood or tissue for Central Nervous System Primary Tumors. Tissue sample. Qty: Minimum 400mg

Analysis period

Approx. 7 days

Cancer type

All types of Cancers

Final results

7–10 days

Sample Size

15–25 ml peripheral whole blood

Price*

2050€

* The prices of the tests may be an issue of local additional taxes and value added taxes which are dependent of each country’s legislation. The prices may vary in areas that are under the jurisdiction of a distributor. These prices are for the tests only, and they do not include in-office fees such as consultation, blood draws, etc.

Find out more about the science behind RGCC tests

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more